Invent Pharmaceuticals

INVENT Pharmaceuticals is developing novel and innovative drugs for the prevention and treatment of serious diseases including Cardiopulmonary and Renal diseases, Fibrotic diseases (NASH, Liver Fibrosis/Cirrhosis, and Neuroendocrine Tumors), Oral Antiviral therapeutics (Deuterated-Paxlovid), and Neurodegenerative diseases (Alzheimer's disease). INVENT Pharma is dedicated to the pursuit of excellence in science to invent safer and highly effective small molecule oral drugs to help patients. INVENT applies its proprietary drug target-specific innovative drug design platform to invent novel, potent, target receptor-selective, and highly effective therapeutics that modulate G-Protein Coupled Receptors (GPCRs) as drug targets. GPCRs have conserved structures of seven transmembrane (7-TM)-spanning helices. INVENT Pharmaceuticals applies and leverages its broad and deep expertise in GPCR drug design, discovery and development to invent best-in-class and first-in-class drugs for unmet medical need to help improve patients' lives.